Elevated plasma 4-pyridoxic acid in renal insufficiency
Authors:
- Stephen P CoburnSCStephen P Coburn
- Robert D ReynoldsRRRobert D Reynolds
- J Dennis MahurenJMJ Dennis Mahuren
- Wayne E SchaltenbrandWSWayne E Schaltenbrand
- Yao WangYWYao Wang
- Karen L EricsonKEKaren L Ericson
- Michael P WhyteMWMichael P Whyte
- Yvonne M ZubovicYZYvonne M Zubovic
- Paula J ZieglerPZPaula J Ziegler
- David L CostillDCDavid L Costill
- William J FinkWFWilliam J Fink
- David R PearsonDPDavid R Pearson
Open Access
- 1 January 2002
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 75 (1) , 57-64
Abstract
Background: Renal insufficiency is associated with altered vitamin B-6 metabolism. We have observed high concentrations of 4-pyridoxic acid, the major catabolite of vitamin B-6 metabolism, in plasma during renal insufficiency. Objective: The objective was to evaluate the renal handling of 4-pyridoxic acid and the effects of renal dysfunction on vitamin B-6 metabolism. Design: We measured the renal clearance of 4-pyridoxic acid and creatinine in 17 nonpregnant, 17 pregnant, and 16 lactating women. We then examined the influence of vitamin B-6 or alkaline phosphatase activity on the ratio of 4-pyridoxic acid to pyridoxal (PA:PL) in plasma in 10 men receiving a low (0.4 mg pyridoxine·HCl/d) or high (200 mg pyridoxine·HCl/d) vitamin B-6 intake for 6 wk, in 10 healthy subjects during a 21-d fast, in 1235 plasma samples from 799 people screened for hypophosphatasia, and in 67 subjects with a range of serum creatinine concentrations. Results: Renal clearance of 4-pyridoxic acid was 232 ± 94 mL/min in nonpregnant women, 337 ± 140 mL/min in pregnant women, and 215 ± 103 mL/min in lactating healthy women. These values were approximately twice the creatinine clearance, indicating that 4-pyridoxic acid is at least partially eliminated by tubular secretion. Elevated plasma creatinine concentrations were associated with marked elevations in 4-pyridoxic acid and PA:PL. PA:PL was not affected by wide variations in vitamin B-6 intake or by the wide range of pyridoxal-P concentrations encountered while screening for hypophosphatasia. Conclusions: Plasma 4-pyridoxic acid concentrations are markedly elevated in renal insufficiency. Plasma PA:PL can distinguish between increases in 4-pyridoxic acid concentrations due to increased dietary intake and those due to renal insufficiency.Keywords
This publication has 36 references indexed in Scilit:
- A Prospective Study of the Intake of Vitamins C and B6, and the Risk of Kidney Stones in MenJournal of Urology, 1996
- Oral Pyridoxine in the Prevention of Oxalate Kidney StonesAmerican Journal of Nephrology, 1996
- B6 vitamers: cation exchange HPLCThe Journal of Nutritional Biochemistry, 1990
- Pharmacokinetic Properties of the Plasma B6 Vitamers after Single and Chronic Oral Pyridoxine Mega DosesAnnals of the New York Academy of Sciences, 1990
- Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism.Journal of Clinical Investigation, 1985
- Synthesis of deuterated vitamin B6 compoundsJournal of Labelled Compounds and Radiopharmaceuticals, 1982
- Transport and metabolism of pyridoxine in rat liverBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Regarding 4-pyridoxic acid-5′-phosphate in animal tissueBiochemical and Biophysical Research Communications, 1972
- 4-pyridoxic acid 5′-phosphate: A metabolite of pyridoxol in the ratBiochemical and Biophysical Research Communications, 1970
- Renal lesions in pyridoxin‐deficient ratsThe Journal of Pathology and Bacteriology, 1951